Our news and insights
15 October 2024
News
Big election day at the EHC Conference 2024: all you have to know about it
The European Haemophilia Consortium (EHC) held its annual General Assembly (GA) during the EHC Conference 2024 in Sofia, Bulgaria, from 4 to 6 October.
29 October 2024
News
The EHC responded to the European Commission’s consultation on the implementation act on Joint Scientific Consultation for Medicinal Products
The EHC welcomed the opportunity to contribute to the European Commission’s public consultation on the draft implementing regulation on Joint Scientific Consultations (JSC) for Medicinal Products, for which we issued nine recommendations.
26 September 2024
Insights
Executive Summary: EHC Round Table on “Current Issues in von Willebrand Disease”
On 10 September 2024, the EHC hosted its first post-pandemic Round Table on “Current Issues in von Willebrand Disease” in Brussels, Belgium.
Latest News and Insights
Filter by category
29 October 2024
News
The EHC responded to the European Commission’s consultation on the implementation act on Joint Scientific Consultation for Medicinal Products
The EHC welcomed the opportunity to contribute to the European Commission’s public consultation on the draft implementing regulation on Joint Scientific Consultations (JSC) for Medicinal Products, for which we issued nine recommendations.
21 October 2024
News
Meet Stéphanie Maya Bravo, EHC Administration Officer
We are delighted to introduce you to our latest EHC addition, Stéphanie Maya Bravo, who joined us in October 2024 as Administration Officer.
15 October 2024
News
Big election day at the EHC Conference 2024: all you have to know about it
The European Haemophilia Consortium (EHC) held its annual General Assembly (GA) during the EHC Conference 2024 in Sofia, Bulgaria, from 4 to 6 October.
26 September 2024
Insights
Executive Summary: EHC Round Table on “Current Issues in von Willebrand Disease”
On 10 September 2024, the EHC hosted its first post-pandemic Round Table on “Current Issues in von Willebrand Disease” in Brussels, Belgium.
25 September 2024
Insights
Update on Novo Nordisk manufacturing deviation for NovoSeven©, resulting in shortages for NovoEight© and Esperoct©
Mid-June 2024, the EHC, NBDF and WFH were made aware of a manufacturing deviation in the production lines of several products for the treatment of haemophilia and other coagulopathies manufactured by Novo Nordisk in Denmark.
24 September 2024
News
Meet Roberta Sadauskaitė, EHC Public Policy Lead
We are delighted to introduce you to our latest EHC addition, Roberta Sadauskaitė, who joined us in September 2024 as Public Policy Lead.
Stay up-to-date with the latest EHC activities and events!